Thromb Haemost 2015; 113(03): 437-438
Schattauer GmbH
Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now?
Theodore E. Warkentin
1
Department of Pathology and Molecular Medicine, and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
› Author Affiliations
References
1
Warkentin TE,
Chong BH,
Greinacher A.
Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998; 79: 1-7.
2
Warkentin TE,
Greinacher A,
Gruel Y.
et al.
Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost 2011; 9: 2498-2500.
3
Maeda T,
Noguchi T,
Saito S.
et al.
Impact of heparin-induced thrombocytopenia on acute coronary artery thrombosis in patients undergoing PCI. Thromb Haemost 2014; 112: 624-626.
4
Zimrin AB,
Warkentin TE.
Transient pseudo-thrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism. Thromb Haemost 2013; 109: 971-973.
5
Ketha S,
Smithedajkul P,
Vella A.
et al.
Adrenal haemorrhage due to heparin-induced thrombocytopenia. Thromb Haemost 2013; 109: 669-675.
6
Greinacher A,
Juhl D,
Strobel U.
et al.
Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 2007; 5: 1666-1673.
7
Lo GK,
Sigouin CS,
Warkentin TE.
What is the potential for overdiagnosis of heparin-induced thrombocytopenia?. Am J Hematol 2007; 82: 1037-1043.
8
Trehel-Tursis V,
Louvain-Quintard V,
Zarrouki Y.
et al.
Clinical and biological features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU. Chest 2012; 142: 837-844.
9
Tardy-Poncet B,
Combe M,
Piot M.
et al.
Effects of argatroban, danaparoid, and fondaparinux on thrombin generation in heparin-induced thrombocytopenia. Thromb Haemost 2013; 109: 504-509.
10
Warkentin TE,
Heddle NM.
Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003; 2: 148-157.
11
Lo GK,
Juhl D,
Warkentin TE.
et al.
Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4: 759-765.
12
Cuker A,
Gimotty PA,
Crowther MA.
et al.
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood 2012; 120: 4160-4167.
13
Cuker A,
Arepally G,
Crowther MA.
et al.
The HIT Expert Probability (HEP) score: a novel pretest probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 2010; 8: 2642-2650.
14
Joseph L,
Gomes MPV,
Al Solaiman F.
et al.
External validation of the HIT Expert Probability (HEP) score. Thromb Haemost 2015; 113: 633-640.
15
Warkentin TE,
Greinacher A.
Laboratory testing for heparin-induced thrombocytopenia. In:
Warkentin TE,
Greinacher A.
eds.
Heparin-Induced Thrombocytopenia. 5th edn.. Boca Raton, FL: CRC Press; 2013. pp. 272-314.
16
Pouplard C,
Gueret P,
Fouassier M.
et al.
Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2007; 5: 1373-1379.
17
Linkins LA,
Bates SM,
Lee AYY.
et al.
Combination of 4T’s score and rapid gel centrifugation assay excludes HIT in a prospective cohort study. Blood (ASH Annual Meeting Abstracts). 2013 122. Abstract 3535.
18
Leroux D,
Hezard N,
Lebreton A.
et al.
Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (Stic Expert* HIT) for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2014; 166: 774-782.
19
Warkentin TE,
Sheppard JI,
Moore JC.
et al.
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoas-says. J Thromb Haemost 2008; 6: 1304-1312.
20
Raschke RA,
Curry SC,
Warkentin TE.
et al.
Improved clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, statum-specific likelihood ratios, and Bayes theorem. Chest 2013; 144: 1269-1275.
